📈 Free macro insights every week — Subscribe Free →
📈 Free macro insights every week — Subscribe Free →

MacroHint

Uncategorized

Sea Limited Is Growing Revenue Nearly 50%. So Why Is Its Stock Getting Crushed?

October 21, 2026 | MacroHint Something about Sea Limited (NYSE: SE) isn’t adding up. The Singapore-based technology company behind Shopee, Garena, and Monee is reporting extraordinary revenue growth, expanding its businesses, and generating hundreds of millions of dollars in quarterly profits. Yet its stock has been hammered. Shares closed at approximately $80.43 on October 20, […]

Sea Limited Is Growing Revenue Nearly 50%. So Why Is Its Stock Getting Crushed? Read More »

Boston Scientific Has Lost More Than Half Its Value in 2026. Here’s Why That’s Remarkable.

October 21, 2026 | MacroHint Boston Scientific (NYSE: BSX), one of America’s largest medical technology companies, has experienced a staggering stock market decline in 2026. Shares closed at $45.58 on October 20, down approximately 52% year to date and nearly 57% below their 52-week high of $105.65. The remarkable part? Boston Scientific is still generating

Boston Scientific Has Lost More Than Half Its Value in 2026. Here’s Why That’s Remarkable. Read More »

Musk’s SpaceX and Tesla Explore Potential $3.5 Trillion Merger

October 21, 2026 | MacroHint Elon Musk confirmed Tuesday that SpaceX (NASDAQ: SPCX) and Tesla (NASDAQ: TSLA) have established independent special committees to explore a potential merger, a transaction that could unite two of the world’s most valuable companies. The announcement came during SpaceX’s third-quarter earnings call, where Musk expressed support for combining the businesses,

Musk’s SpaceX and Tesla Explore Potential $3.5 Trillion Merger Read More »

Fox’s $22 Billion Roku Deal: The Battle to Control What America Watches

Fox’s $22 Billion Roku Deal: The Battle to Control What America Watches Fox is buying one of the country’s most important streaming platforms in a transaction that could reshape television. The real prize is not another library of shows. It is the technology, advertising relationships, and television screens through which millions of households access entertainment.

Fox’s $22 Billion Roku Deal: The Battle to Control What America Watches Read More »

H.B. Fuller Turns Down $1.4 Billion: The Battle Over What an Adhesives Business Is Really Worth

H.B. Fuller Turns Down $1.4 Billion: The Battle Over What an Adhesives Business Is Really Worth Activist investor Ancora wants to buy one of H.B. Fuller’s major divisions. Management says the offer is too low. Behind the dispute is a much larger question about corporate breakups, debt, and whether a business can be worth more

H.B. Fuller Turns Down $1.4 Billion: The Battle Over What an Adhesives Business Is Really Worth Read More »

Jersey Mike’s Financial Statements: The Good, the Bad, and the Ugly Behind America’s Sandwich Empire

Jersey Mike’s Financial Statements: The Good, the Bad, and the Ugly Behind America’s Sandwich Empire Revenue is growing, the franchise model is attractive, and cash generation has recently improved. But beneath Jersey Mike’s expansion lies a complicated financial picture involving rising debt, deteriorating profits, billions in intangible assets, and an ownership structure that investors cannot

Jersey Mike’s Financial Statements: The Good, the Bad, and the Ugly Behind America’s Sandwich Empire Read More »

Bumble’s $1.3 Billion Exit: What Went Wrong With the Business of Finding Love?

Bumble’s $1.3 Billion Exit: What Went Wrong With the Business of Finding Love? Five years after reaching a valuation of roughly $14 billion, Bumble is leaving the public market. Its sale to Ithaca Holdings reveals the difficult economics of online dating, the changing habits of younger users, and why finding a match has become an

Bumble’s $1.3 Billion Exit: What Went Wrong With the Business of Finding Love? Read More »

Labcorp’s $872 Million Bet: The Bigger Story Behind the BioReference Deal

Labcorp’s $872 Million Bet: The Bigger Story Behind the BioReference Deal An acquisition involving a prostate cancer blood test, a shrinking laboratory business, and two companies pursuing very different futures reveals where the economics of American diagnostics may be heading. MacroHint | October 19, 2026 There is a peculiar feature of the medical testing business:

Labcorp’s $872 Million Bet: The Bigger Story Behind the BioReference Deal Read More »

The Businesses That Look Normal But Are Secretly Kind of Terrible

Introduction There’s a quiet divide in public markets that doesn’t show up neatly in valuation screens or earnings reports. On one side are businesses that look like they should work — stable demand, real assets, established customers, familiar industries. On the other side are businesses that actually compound capital over time. The uncomfortable truth is

The Businesses That Look Normal But Are Secretly Kind of Terrible Read More »

Nancy Pelosi’s Portfolio Shows One Clear Investment Theme: Owning the Companies Building the Digital Economy

Sponsored by Lake Region State College This article is proudly sponsored by Lake Region State College. Lake Region State College provides students with affordable, career-focused education designed to create real-world opportunities. Through academic programs, workforce training, and transfer pathways, LRSC helps students develop the skills needed for their next stage of their professional journey. The

Nancy Pelosi’s Portfolio Shows One Clear Investment Theme: Owning the Companies Building the Digital Economy Read More »